2Greenlee RT,Murray T,Bolden S,et al.Cancer statistics 2000[J].CA Cancer J Clin,2000,50(1):7.
3Kim DS,McCabe CJ,Buchana MA,et al.Oncogenes in thyroid cancer [J ].Clin Otolaryngol Allied Sci,2003,28 (5):386.
4Raflhellac,Minerva MA,Ruben H,et al.Frequent RET rearrangements in thyroid papillary microcacinoma detected by interphase fluorescence in situ hybridization[J ].Lab Invest,2001,81(12):1639.
5Kalinin VN,Amosenko FA,Shabanov MA,et al.Three novel mutations in the RET proto-oncogene [J ].J Mol Med,2001,79(10):609.
6Melillo RM,Cirafici AM,De Falco V,et al.The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma[J ].Am J Pathol,2004,165(2):511.
7Schramm A,Apostolov O,Sitek B,et al.Proteomics:techniques and applications in cancer research [J ].Klin Padiatr,2003,215(6):293.
8Anderson L,Seilhamer J.A comparison of selected mRNA and protein abundances in human liver [J ].Electrophoresis,1997,18(3～4):533.
9Hampel DJ,Sansome C,Sha M,et al.Toward Proteomics in Uroscopy:Urinary Protein Profiles after Radiocontrast Medium Administration [J].J Am Soc Nephrol,2001,12 (5):1026.
10Harris RA,Yang A,Stein RC,et al.Cluster analysis of anextensive human breast cancer cell line protein expression map database [J ].Proteomics,2002,2(2):212.
同被引文献10
1Xing MZ. BRAF mutation in thyroid cancer [ J]. Endocri Rela Cancer, 2005,12 (2) : 245.
2Ciampi R, Nikiforov YE. RET/PTC rearrangements and B- RAF mutations in thyroid tumorigenesis [ J ]. Endorcrinolo- gy ,2007,148 ( 3 ) :936.
3Czarniecka A, Rusinek D, Stobiecka E, et al. Occurrence of BRAF mutation in a Polish cohort of PTC patients-prelimi- na,y results[ J]. Endokrynol Pol,2010,61 (5) :462.
4Fugazzola L, Puxeddu E, Avenia N, et al. Correlation be- tween BRAFV600E mutation and clinico-pathologic param-eters in papillary thyroid carcinoma:data from a multicen- tric Italian study and review of the literature [J]. Endocr Relat Cancer,2006,13 ( 2 ) :455.
5Ouyang B, Knauf JA, Smith EP, et al. lnhibitors of Raf ki- nase activity block growth of thyroid cancer cells with RET/ tYFC or BRAF mutation in vitro and in vivo [J]. Clin Cancer Res,2006,12(6) : 1785.
6Wan PT, Garnett M J, Roe SM, et al. Mechanism of activa- tion of the RAF-ERK signaling pathway by oncogenic muta- tions of B-RAF[ J]. Ce11,2004,116(6) :855.
7Nucera C, Polxello A, Antonello ZA, et al. B-raf(V600E) and thrombospondin-1 promote thyroid cancer progression [ J]. Proc Natl Acad Sci USA,2010,107 (23) : 10649.
8Hu S, Liu DX, Tufano RP, et al. Association of aberrant methylation of tumor suppressor genes with tumor aggres- siveness and BRAF mutation in papillary thyroid cancer[J]. Int J Cancer,2006,119(10) :2322.
